ImmuGT-ConRes: a consistency learning residual network for predicting pan-cancer immunotherapy response from gene...

Area of Science:

• Oncology
• Immunology
• Bioinformatics
• Computational Biology

Background:

• Immunotherapy is revolutionizing cancer treatment but faces challenges with low response rates and a limited number of durable immune targets.
• Multi-omics data holds promise for immunotherapy research, yet traditional analysis methods often fail to reveal crucial correlations, hindering the discovery of new therapeutic targets.
• Existing analytical techniques struggle to fully leverage the complexity of multi-omics data for identifying effective immunotherapy targets.

Purpose of the Study:

• To develop an advanced computational framework for analyzing multi-omics immunotherapy data to identify novel, durable immune targets.
• To enhance the discovery of potential immunotherapy targets by overcoming limitations in traditional data analysis methods.
• To improve the predictive performance and interpretability of models used in immunotherapy target mining.

Main Methods:

• Developed ImmuGT-ConRes (Genomic Image Transformation with Consistency Learning and Residual Networks), a novel computational framework integrating contrastive learning, dual-branch data augmentation, and multi-scale residual networks.
• Employed a multi-scale stride convolution structure and attention mechanisms to capture multi-scale gene features, minimize information loss, and improve robustness.
• Pooled and analyzed multi-omics immunotherapy data from over 40 independent cohorts.

Main Results:

• ImmuGT-ConRes demonstrated superior predictive performance in analyzing multi-omics immunotherapy data.
• The model provided interpretability by ranking gene weights using an attention mechanism, effectively highlighting potential immunotherapy targets.
• The framework successfully identified hidden correlations within the data, facilitating the exploration of novel immune targets.

Conclusions:

• ImmuGT-ConRes offers a powerful and interpretable approach for immunotherapy target discovery using multi-omics data.
• The developed framework shows significant promise for advancing cancer immunotherapy by identifying targets that may lead to lasting clinical effects.
• Further investigation into ImmuGT-ConRes is warranted to fully realize its potential in precision oncology and immunotherapy development.